KAZIA RAISES A$4.5 MILLION TO PROGRESS R&D PROGRAMS
- Monday, January 16, 2023, 7:12
- PR Newswire
- Add a comment
SYDNEY, Jan. 16, 2023 /PRNewswire/ — Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce a placement of KZA shares, to institutional and sophisticated investors in Australia, at a price of A$0.11 per share. The…
About the Author
admin has written 20655 stories on this site.